1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 CENTRAL DISTRICT OF CALIFORNIA 10 11 LEONARDO A.,1 Case No. 2:19-cv-05395-MAA 12 Plaintiff,

MEMORANDUM DECISION AND

13 v. ORDER AFFIRMING DECISION OF

THE COMMISSIONER

14 15 ANDREW M. SAUL,2 Commissioner of Social Security, 16 Defendant. 17 18 19 On June 20, 2019, Plaintiff filed a Complaint seeking review of the Social 20 Security Commissioner’s final decision denying his application for a period of 21 disability and disability insurance benefits pursuant to Title II of the Social Security 22 Act. This matter is fully briefed and ready for decision. For the reasons discussed 23 below, the Court affirms the final decision of the Commissioner. 24

25 1 Plaintiff’s name is partially redacted in accordance with Federal Rule of Civil Procedure 5.2(c)(2)(B) and the recommendation of the Committee on Court 26 Administration and Case Management of the Judicial Conference of the United States. 27 2 The Commissioner of Social Security is substituted as the Defendant pursuant to 28 Federal Rule of Civil Procedure 25(d). 1 PROCEDURAL HISTORY 2 On September 17, 2015, Plaintiff filed an application for a period of 3 disability and disability insurance benefits, alleging disability beginning on May 8, 4 2015. (Administrative Record (“AR”) 181-84.) Plaintiff alleged disability because 5 of a neck injury, a herniated disc, a slipped disc, a lower back injury, numbness and 6 tingling in his hands and feet, a shoulder injury, and diabetes. (AR 215.) 7 Plaintiff’s application was denied. (AR 105-10.) Plaintiff requested a 8 hearing before an Administrative Law Judge (“ALJ”). (AR 178-80.) On December 9 13, 2017, ALJ Bruce Cooper held a hearing. Plaintiff appeared with counsel and 10 testified at the hearing. (AR 44-92.) 11 In a decision issued on April 26, 2018, the ALJ denied Plaintiff’s application. 12 (AR 7-27.) The ALJ made the following findings pursuant to the Commissioner’s 13 five-step evaluation: first, Plaintiff had not engaged in substantial gainful activity 14 since his alleged disability onset date. (AR 12.) Second, he had the following 15 severe impairments: degenerative disc disease of the cervical and lumbar spine; 16 diabetes mellitus; neuropathy; left shoulder bursitis; and obesity. (AR 28-30.) 17 Third, he did not have an impairment or combination of impairments that met or 18 medically equaled the requirements of one of the impairments from the 19 Commissioner’s Listing of Impairments. (AR 30-31.) 20 Fourth, Plaintiff had a residual functional capacity (“RFC”) to perform light 21 work with the following limitations: he could not lift or carry more than 20 pounds 22 occasionally and 10 pounds frequently, and he could not stand or walk for more 23 than six hours in an eight-hour workday. Plaintiff could push and pull as much as 24 he could lift and carry, but was limited to occasional overhead reaching with the left 25 upper extremity. He could climb ramps and stairs frequently; climb ladders, ropes, 26 and scaffolds occasionally; balance frequently; and stoop, kneel, crouch, and crawl 27 occasionally. Plaintiff could work at unprotected heights frequently; work with 28 /// 1 moving mechanical parts frequently; and be exposed to dust, fumes, odors, 2 pulmonary irritants, extreme cold, and vibration frequently. (AR 31-38.) 3 At the fifth step, the ALJ found that Plaintiff could perform his past relevant 4 work as a press machine operator. (AR 38.) The ALJ thus concluded that Plaintiff 5 was not disabled as defined by the Social Security Act. (AR 39.) 6 On April 30, 2019, the Appeals Council denied Plaintiff’s request for review. 7 (AR 1-9.) Thus, ALJ’s decision became the final decision of the Commissioner. 8 9 DISPUTED ISSUE 10 The parties raise the following disputed issue: 11 1. Whether the ALJ properly considered Plaintiff’s testimony. 12 (Joint Stipulation (“JS”) 4.) 13 14 STANDARD OF REVIEW 15 Under 42 U.S.C. § 405(g), the Court reviews the Commissioner’s final 16 decision to determine whether the Commissioner’s findings are supported by 17 substantial evidence and whether the proper legal standards were applied. See 18 Treichler v. Commissioner of Social Sec. Admin., 775 F.3d 1090, 1098 (9th Cir. 19 2014). Substantial evidence means “more than a mere scintilla” but less than a 20 preponderance. See Richardson v. Perales, 402 U.S. 389, 401 (1971); Lingenfelter 21 v. Astrue, 504 F.3d 1028, 1035 (9th Cir. 2007). Substantial evidence is “such 22 relevant evidence as a reasonable mind might accept as adequate to support a 23 conclusion.” Richardson, 402 U.S. at 401. The Court must review the record as a 24 whole, weighing both the evidence that supports and the evidence that detracts from 25 the Commissioner’s conclusion. Lingenfelter, 504 F.3d at 1035. Where evidence is 26 susceptible of more than one rational interpretation, the Commissioner’s 27 interpretation must be upheld. See Orn v. Astrue, 495 F.3d 625, 630 (9th Cir. 28 2007). 1 DISCUSSION 2 A. Legal Standard. 3 Once a claimant produces medical evidence of an underlying impairment that 4 is reasonably likely to cause alleged subjective symptoms, the ALJ may reject a 5 claimant’s allegations upon: (1) finding evidence of malingering; or (2) providing 6 clear and convincing reasons, supported by substantial record evidence, for so 7 doing. Benton v. Barnhart, 331 F.3d 1030, 1040 (9th Cir. 2003); see Bunnell v. 8 Sullivan, 947 F.2d 341, 345 (9th Cir. 1991). The ALJ’s determination must be 9 “sufficiently specific to allow a reviewing court to conclude the adjudicator rejected 10 the claimant’s testimony on permissible grounds and did not arbitrarily discredit a 11 claimant’s testimony . . . .” Bunnell, 947 F.2d at 345 (internal quotation marks 12 omitted). 13 14 B. Background. 15 1. Objective medical evidence. 16 a. Left shoulder. 17 In December 2006, Plaintiff injured his left shoulder at work. He complained 18 of pain in the neck and left shoulder. (AR 361-68.) A February 2007 left shoulder 19 MRI revealed degenerative change at the acromioclavicular joint and humeral head 20 with narrowing of the shoulder joint, representing mild degenerative change; and 21 slight increased signal at the distal supraspinatus tendon, representing probable 22 tendinitis. (AR 465.) In July 2015, a treating physician found decreased range of 23 motion in Plaintiff’s left shoulder, with reports of pain. (AR 772.) Plaintiff had 24 normal strength and range of motion in November 2015, with no positive findings 25 or evidence of atrophy. (AR 947-48.) 26 At his January 2016 consulting examination, Plaintiff had tenderness in the 27 left shoulder and difficulty fully raising the arm, but his range of motion was 28 grossly within normal limits. (AR 302.) In April 2016, a treating physician found 1 left shoulder impingement and a positive Hawkins sign on physical examination, 2 with decreased range of motion by less than 100 degrees. (AR 841.) In August 3 2016, Plaintiff had a left shoulder injection. (AR 840.) That same month, Plaintiff 4 reported that the injection improved his symptoms by 50%, with only a slight return 5 of symptoms. (AR 833.) Plaintiff reported that as a result, he was not interested in 6 left shoulder surgery. (AR 834.) Plaintiff’s treating physician reported 7 “significantly improved” range of motion. (Id.) 8 9 b. Lumbar spine and cervical spine. 10 In July 2010, Plaintiff slip and fell at work and suffered an injury to his back 11 and hip. (AR 516.) In August 2010, he was diagnosed with lumbar strain and 12 radiculopathy. (AR 486.) The injury was treated with painkillers and physical 13 therapy. (See AR 486, 507.) A February 2011 radiography of Plaintiff’s lumbar 14 spine revealed a 5.2mm central disc protrusion at L4-L5, with mild thecal sac 15 impression, bilateral facet arthrosis, and mild to moderate foraminal narrowing. 16 (AR 802.) At L5-S1, the radiography revealed a 2.8mm circumferential disc bulge, 17 with mild thecal sac impression, mild bilateral facet arthrosis, and mild bilateral 18 neural foraminal narrowing. (AR 803.) 19 After the May 2015 alleged onset date, Plaintiff reported increasing pain in 20 his neck and back. Plaintiff described the pain as continuous aching, often 21 becoming sharp and shooting pain, with episodes of numbness and tingling. The 22 pain increased with activity. (See, e.g., AR 770-71, 855-56.) In July 2015, 23 Plaintiff’s treating physician reported slightly decreased range of motion in 24 Plaintiff’s cervical spine, with reported discomfort. (AR 772.) As to Plaintiff’s 25 lumbar spine, the treating physician reported slightly decreased range of motion, 26 with pain and discomfort and positive signs on the right. (AR 773-74.) During this 27 period, Plaintiff was prescribed a topical agent for his lumbar pain. (AR 842, 862.) 28 /// 1 Plaintiff reported that the lotion provided pain relief and improved his functional 2 status. (AR 841-42.) 3 At his January 2016 consulting examination, Plaintiff had grossly normal 4 range of motion in his cervical spine. (AR 301.) He had localized tenderness in his 5 lumbar spine, with reduced range of motion and no evidence of radiculopathy. (AR 6 302.) A July 2016 MRI of Plaintiff’s lumbar spine revealed a disc protrusion at L4- 7 L5 and L5-S1 with lateral recess stenosis, mainly on the right side. (AR 721, 864- 8 65.) In August 2016, Plaintiff reported to a treating physician that he did not want 9 injections or surgery for his neck or back. (AR 839.) 10 In May 2017, Plaintiff reported to a treating physician that he had constant 11 and more severe lower back pain which radiated down his left leg. (AR 720.) 12 Physical examination revealed tenderness and spasm over the lumbar spine with 13 decreased range of motion and positive straight left leg raising, with decreased 14 sensation over the L5 and S1 distributions on the left side. (AR 721.) Plaintiff’s 15 physician recommended an L4-L5 epidural injection. (Id.) In July 2017, however, 16 the physician reported that Plaintiff was not undergoing any therapy or other 17 treatment modalities for his neck and back. (AR 715.) 18 19 c. Diabetes. 20 Plaintiff had a history of non-insulin-dependent diabetes mellitus. (See AR 21 499.) In February 2014, Plaintiff had a blood glucose level of 249 mg/dL. (AR 22 288.) In November 2015, plaintiff’s blood glucose level was 273 mg/dL and his 23 hemoglobin Alc level was 11.2%.3 (AR 326, 328.) Plaintiff was prescribed 24 metformin, but by October 2015, he had stopped taking it. (AR 321.) In December 25 /// 26 27 3 According to the lab report, the “reference” range for blood glucose level is 65-99 mg/dL. (AR 326.) The reference range for hemoglobin A1c level is <5.7%. (AR 28 328.) 1 2015, he reported to a treating source that he was not checking his blood sugar 2 regularly. As well, he denied numbness and tingling. (AR 318.) 3 In January 2016, Plaintiff’s blood glucose level measured 312 mg/dL. (AR 4 330.) In his consulting examination that same month, Plaintiff reported paresthesia 5 and numbness at the bottom of his feet. (AR 302.) In April 2016, his blood 6 glucose level was 194 mg/dL. (AR 334.) He was diagnosed with type II diabetes 7 mellitus “with other diabetic kidney complication.” (AR 314.) 8 By October 2016, Plaintiff’s hemoglobin Alc level had dropped to 8.1%. 9 (AR 337.) His blood glucose level measured 140 mg/dL. (AR 334.) In January 10 2017, a treating source described Plaintiff’s diabetes as “stable” and “without 11 complications.” (AR 308-09.) The treating source noted, “[Patient] has been 12 improving with diet and exercise, A1C has decreased in recent years . . . .” (AR 13 308.) That same month, Plaintiff’s hemoglobin Alc level measured 8.7% and his 14 blood glucose level measured 165 mg/dL. (AR 339, 341.) In May 2017, Plaintiff 15 reported to a treating physician that his diabetes was under control. (AR 720.) The 16 record does not indicate that Plaintiff suffered end organ damage, vision problems, 17 or hand problems resulting from his diabetes. (See generally AR 258 et seq.) 18 19 d. Depression and anxiety. 20 Prior to the May 2015 disability onset date, Plaintiff had multiple emergency 21 room visits during which he sought treatment for symptoms of anxiety, such as 22 difficulty sleeping and a rapid heartbeat. His symptoms were treated with anti- 23 anxiety medication, such as lorazepam. (See, e.g., AR 266, 290-91, 384, 386, 551.) 24 After his work-related injuries, he sometimes reported additional symptoms such as 25 social isolation and feelings of helplessness and hopelessness. He attributed his 26 overall worsened mood to the physical and financial losses resulting from the 27 injuries. (See, e.g., AR 726, 734, 738, 760.) 28 /// 1 In November 2015, Plaintiff reported numerous symptoms of anxiety and 2 depression. (AR 751, 761.) His Beck Anxiety Inventory (“BAI”) revealed severe 3 positive findings and his Beck Depression Inventory (“BDI”) revealed moderate 4 positive findings. (AR 751-52.) Plaintiff’s June 2016 BAI and BDI indicated 5 moderate depression and high anxiety. (AR 905.) As of June 2016, however, he 6 was not taking any psychiatric medication. (AR 911.) Rather, his symptoms were 7 treated with group therapy and relaxation techniques. (See AR 734, 764.) In May 8 2016, Plaintiff reported some improvement in his symptoms as a result of 9 treatment. (AR 734.) The record does not indicate that Plaintiff was ever 10 hospitalized in a psychiatric facility. (See generally AR 258 et seq.) 11 12 2. Plaintiff’s testimony. 13 At the hearing, Plaintiff testified that he had problems with his left arm and 14 back. (AR 63-64.) These problems caused him to experience pain and difficulty 15 when he tried to work. (AR 64.) He worked at See’s Candies as a picker from 16 November 2016 to January 2017, but the job ended because it required too much 17 bending and overhead work. (AR 50, 58-59, 63-64.) He worked at Aero Tech in a 18 janitorial position for two months in 2017. (AR 50-51.) The job ended because it 19 involved a lot of weights, bending, and overhead reaching, which was too hard for 20 him. (AR 56-58.) 21 Plaintiff testified that he lived with his wife and three of his children. (AR 22 53.) His wife worked the night shift at a factory, putting in 40 to 50 hours a week. 23 (AR 54-55.) Plaintiff had a driver’s license and drove twice a day to take his 24 children to and from their respective schools. (AR 51-52, 55-56.) 25 Plaintiff testified that he could lift no more than 20 pounds and could stand or 26 walk for no longer than one hour. (AR 64.) Plaintiff testified that being outside of 27 the house caused him anxiety, for which he took medication. (AR 65-66.) 28 /// 1 3. The ALJ’s rationale. 2 The ALJ found that while Plaintiff’s medically determinable impairments 3 could reasonably be expected to cause Plaintiff’s alleged symptoms, “[Plaintiff’s] 4 statements concerning the intensity, persistence, and limiting effects of these 5 symptoms are not entirely consistent with the medical evidence and other evidence 6 in the record for the reasons explained in this decision.” (AR 32.) The ALJ 7 asserted, “[D]espite [Plaintiff’s] allegations of pain and limited functioning, the 8 objective medical findings in the record revealed largely unremarkable findings and 9 symptoms that were otherwise reasonably controlled with conservative treatment 10 modalities.” (AR 32.) 11 12 C. Analysis. 13 Plaintiff asserts that an ALJ may not discount allegations of pain merely 14 because the objective medical evidence does not support them. (JS 7 (citing 15 Bunnell, 947 F.2d at 345).) Plaintiff is correct. An ALJ may not premise the 16 rejection of the claimant’s testimony regarding subjective symptoms solely on the 17 lack of medical support. Light v. Social Sec. Admin., 119 F.3d 789, 792 (9th Cir. 18 1997); Lester v. Chater, 81 F.3d 821, 834 (9th Cir. 1995). This approach “reflects 19 the highly subjective and idiosyncratic nature of pain and other such symptoms.” 20 Smolen v. Chater, 80 F.3d 1273, 1282 (9th Cir. 1996). 21 However, contrary to Plaintiff’s assertion (JS 7), the ALJ did not discount 22 Plaintiff’s testimony regarding his subjective symptoms solely because it lacked 23 objective medical support. Rather, the ALJ relied, as well, on Plaintiff’s 24 conservative medical treatment. (See AR 32.) As discussed below, both grounds 25 for discounting Plaintiff’s subjective symptoms were clear, convincing, and 26 supporting by substantial evidence. 27 /// 28 /// 1 1. The lack of objective medical support. 2 Although an ALJ may not premise the rejection of the claimant’s testimony 3 regarding subjective symptoms solely on the lack of medical support (Light, supra; 4 Lester, supra), weak objective support may undermine subjective complaints of 5 disabling symptoms. Regennitter v. Commissioner of Soc. Sec. Admin., 166 F.3d 6 1294, 1297 (9th Cir. 1999) (ALJ’s finding that subjective complaint is “inconsistent 7 with clinical observations” can constitute clear and convincing reason for rejecting 8 testimony if supported by specific findings). Here, the ALJ discussed the clinical 9 record at length and resolved conflicts therein according to his medical judgment. 10 (See AR 29-30, 32-34.) 11 With respect to Plaintiff’s cervical and lumbar spine, the ALJ emphasized 12 that the clinical findings from July 2015 showed minimally decreased range of 13 motion in the cervical spine, and discomfort rather than pain. (AR 33.) Further, at 14 the January 2016 consulting examination, Plaintiff had grossly normal motion in 15 the cervical spine and no more than local tenderness and limited range of motion in 16 the lumbar spine, with no muscle spasm or radiculopathy. (Id.) The ALJ 17 acknowledged the findings from November 2015 and May 2017, which included 18 objective evidence of pain and tenderness. (See AR 32-33.) However, the ALJ 19 evidently found the July 2015 and January 2016 findings more persuasive. 20 Similarly, the ALJ acknowledged Plaintiff’s cervical spine and lumbar spine 21 imaging, but did not find that the imaging supported Plaintiff’s claims of disabling 22 pain. (See id.) Although the objective evidence could rationally support an 23 interpretation more favorable to Plaintiff, the ALJ’s interpretation is reasonable. 24 Therefore, the Court must defer to it. See Orn, supra; see also Batson v. Comm’r of 25 Soc. Sec. Admin., 359 F.3d 1190, 1193 (9th Cir. 2004) (“When the evidence before 26 the ALJ is subject to more than one rational interpretation, [the court] must defer to 27 the ALJ’s conclusion”). 28 /// 1 Regarding Plaintiff’s left shoulder, the ALJ took note of the July 2015 2 findings of painful, decreased range of motion and the April 2016 findings of 3 decreased range of motion and left shoulder impingement. (AR 34.) The ALJ gave 4 greater weight, however, to the November 2015 and January 2016 findings of 5 normal/generally normal range of motion and strength. (Id.) The ALJ cited, in 6 addition, Plaintiff’s August 2016 left shoulder injection, which resulted in 7 significantly improved range of motion and a reported 50% decrease in symptoms. 8 In light of the foregoing evidence, the ALJ reasonably concluded that the medical 9 evidence undermined Plaintiff’s claims regarding his left shoulder subjective 10 symptoms. 11 As to Plaintiff’s diabetes and related symptoms, the ALJ reviewed Plaintiff’s 12 blood glucose and hemoglobin Alc levels from February 2014 through January 13 2017. (AR 33.) As set forth above, Plaintiff’s blood glucose level measured 249 14 mg/dL in February 2014, but was down to 165 mg/dL by January 2017. Plaintiff’s 15 hemoglobin Alc levels followed a similar trajectory, measuring 11.2% in November 16 2015 and 8.7% in January 2017. The ALJ acknowledged that Plaintiff’s levels 17 were “elevated,” but emphasized that (1) they were trending downwards; and (2) 18 there was no evidence that Plaintiff suffered end organ damage, vision problems, or 19 hand problems as a result of his diabetes. (AR 33.) Therefore, the ALJ reasonably 20 found that the objective evidence undermined Plaintiff’s subjective claims 21 regarding his diabetes. 22 Finally, after reviewing Plaintiff’s mental health records, the ALJ concluded 23 that Plaintiff’s anxiety and depression were nonsevere4 because (inter alia) 24 Plaintiff’s mental status examinations revealed “negative findings.” (AR 29.) As 25 Plaintiff’s November 2015 and June 2016 BAI and BDI scores were positive for 26 27 4 Plaintiff does not challenge the ALJ’s nonseverity finding per se. (See generally JS.) Because Plaintiff testified to being anxious when leaving the house, the Court 28 addresses the finding out of an abundance of caution. 1 anxiety and depression, the Court is dubious of the ALJ’s reasoning. However, 2 because the ALJ provided other, valid grounds for finding Plaintiff’s anxiety and 3 depression nonsevere, the Court concludes that any error was harmless. See Stout 4 v. Commissioner, Soc. Sec. Admin., 454 F.3d 1050, 1055 (9th Cir. 2006) (ALJ’s 5 error is harmless where it is “inconsequential to the ultimate nondisability 6 determination”); see also Batson, 359 F.3d at 1197 (error in asserting that plaintiff 7 sat while watching television was harmless where ALJ provided numerous other 8 reasons supported by substantial evidence for discounting plaintiff’s testimony). 9 10 2. Conservative treatment; lack of treatment; effective treatment. 11 Evidence of conservative treatment is sufficient to discount a claimant’s 12 testimony regarding the severity of an impairment. Parra v. Astrue, 481 F.3d 742, 13 751 (9th Cir. 2007). So is evidence of a lack of treatment, Burch v. Barnhart, 400 14 F.3d 676, 681 (9th Cir. 2005), or an unexplained or inadequately explained failure 15 to seek treatment or follow a prescribed course of treatment, Fair v. Bowen, 885 16 F.2d 597, 603 (9th Cir. 1989). Here, as the ALJ emphasized (AR 33), Plaintiff’s 17 treating physicians recommended epidural injections and/or surgery for Plaintiff’s 18 neck and back, but Plaintiff declined to pursue those treatment options. Rather, 19 after the alleged onset date, Plaintiff merely used a topical agent for his back. And 20 as the ALJ asserted (id.), the record indicates that in July 2017, Plaintiff was 21 reportedly not undergoing any therapy or other treatment for his spinal 22 impairments. 23 Plaintiff asserts that he has not undergone cervical or lumbar surgery because 24 he is afraid of surgery generally. (JS 9 (citing AR 60-62 (hearing testimony 25 indicating that Plaintiff skipped a scheduled hernia surgery out of fear)).) Plaintiff 26 asserts, as well, that surgery for his neck and back has been suggested rather than 27 prescribed. “‘It is improper,’” Plaintiff argues, “‘to deny benefits on the basis of 28 declined surgery, when surgery is only a suggested rather than a prescribed course 1 of treatment.’” (JS 8 (quoting Aguirre v. Astrue, 2009 WL 3346741, at *5 (C.D. 2 Cal. Oct. 14, 2009)).) These arguments do not avail Plaintiff. First, the record 3 reflects that Plaintiff is not entirely surgery-avoidant, in that he has a reported 4 history of gallbladder and jaw surgeries. (See AR 300.) Second, the fact remains 5 that after the alleged onset date, Plaintiff’s treatment for his neck and back was 6 limited or nonexistent. Therefore, the ALJ reasonably concluded that Plaintiff’s 7 conservative treatment undermined his subjective claims with regard to those 8 impairments. 9 Plaintiff did undergo an injection for his shoulder. And as the ALJ noted 10 (AR 34), Plaintiff reported a significant decrease in symptoms as a result. An ALJ 11 may discredit a claimant’s subjective claims regarding the severity of an 12 impairment where the record reflects that the impairment is controlled by treatment. 13 See Tommasetti v. Astrue, 533 F.3d 1035, 1040 (9th Cir. 2008) (ALJ reasonably 14 discounted plaintiff’s complaints of disabling pain and diabetes where plaintiff 15 responded favorably to, e.g., physical therapy and lumbosacral corset and diabetes 16 was controlled by medication). Therefore, the ALJ reasonably found Plaintiff less 17 than credible with regard to his testimony of disabling shoulder symptoms. 18 As to Plaintiff’s diabetes, the ALJ correctly noted that Plaintiff reported 19 noncompliance with his diabetes management in October 2015 and April 2016. 20 (AR 33.) Arguably, Plaintiff’s failure to follow his prescribed diabetes treatment is 21 a permissible ground for finding him less than credible with regard to his claims of 22 disabling diabetes symptoms. See Fair, supra. And as the ALJ noted (AR 33), a 23 treating source noted in January 2017 that Plaintiff had been “improving with diet 24 and exercise,” and Plaintiff reported in May 2017 that his diabetes was under 25 control. As the treating source indicated (see AR 308), Plaintiff’s improvement in 26 diabetes management coincided with a decrease in his blood glucose and 27 hemoglobin A1c levels. Therefore, the ALJ reasonably concluded that Plaintiff’s 28 diabetes “should be amenable to proper control by adherence to recommended 1 medical management and medication compliance.” (AR 33.) In turn, the 2 impairment’s amenability to proper treatment undermined his claims of disabling 3 symptoms. See Tommasetti, supra. 4 With regard to Plaintiff’s depression and anxiety, the ALJ acknowledged 5 Plaintiff’s history of ER visits for anxiety. (AR 29.) The ALJ noted, however, that 6 (1) Plaintiff had never been hospitalized in a psychiatric facility; and (2) as of June 7 2016, Plaintiff was not taking any psychiatric medications. (Id.) This evidence of 8 conservative treatment (or no treatment) was sufficient to discount Plaintiff’s 9 claims of disabling anxiety. See Parra, supra; see Burch, supra; see also AR 32 10 (asserting that Plaintiff’s claimed limitations were “not entirely consistent” with 11 “other evidence in the record”). 12 13 3. Plaintiff’s daily activities. 14 An ALJ may discredit a claimant’s allegations by pointing to evidence that 15 he is able to engage in activities that would translate to a workplace setting, upon 16 making specific findings relating to those activities. Burch, 400 F.3d at 680-81. 17 The relevant question, however, is whether the physical activities at issue consume 18 a “substantial part” of the claimant’s day. Vertigan v. Halter, 260 F.3d 1044, 1050 19 (9th Cir. 2001). “[M]any home activities are not easily transferrable to what may 20 be the more grueling environment of the workplace, where it may be impossible to 21 periodically rest or take medication.” Fair, 885 F.2d at 603. 22 Here, at step four of the sequential evaluation process, the ALJ recited 23 Plaintiff’s testimony regarding his daily activities. (AR 32.) However, the ALJ did 24 not explicitly find that this testimony was inconsistent with his claims of disabling 25 pain and other subjective symptoms. (See id.) Plaintiff argues, accordingly, that 26 the Court may not rely on Plaintiff’s daily activities as grounds for upholding the 27 ALJ’s decision. (JS 9; see Garrison v. Colvin, 759 F.3d 995, 1010 (9th Cir. 2014) 28 (“We review only the reasons provided by the ALJ in the disability determination 1 || and may not affirm the ALJ on a ground upon which he did not rely’’).) Plaintiff 2 |} argues, in addition, that his daily activities do not demonstrate that he is capable of 3 || maintaining substantial gainful activity. (JS 9-11.) Because the ALJ provided 4 || other, valid grounds for discounting Plaintiffs testimony, the Court need not 5 || consider these arguments.° See Batson, 359 F.3d at 1197. 6 7 ORDER 8 It is ordered that Judgment be entered affirming the final decision of the 9 || Commissioner of Social Security. 10 11 || DATED: July 31, 2020

13 MARIA’A. AUDERO 1a UNITED STATES MAGISTRATE JUDGE

15 16 17 18 19 20 21 22 23 24 || ° The Court notes here that the ALJ properly evaluated Plaintiff's mental 5 || functioning using the psychiatric review technique set forth in 20 C.F.R. § 404.1520a. (See AR 29-30.) In so doing, the ALJ explicitly and reasonably 26 | found, as relevant, that Plaintiff's reported self-management abilities — which >7 || included driving, doing light housework, shopping independently, and preparing meals — indicated that his mental impairments were nonsevere. (AR 30 (citing AR 28 || 902); see 20 C.F.R. § 404.1520a(c)(3).) 15